FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4200430478> ?p ?o ?g. }

• W4200430478 abstract "Autism spectrum disorder is a neurodevelopmental disorder characterized by deficits in communication, social interaction, restricted interest, and repetitive behaviors. Although more cases are being diagnosed, no drugs are approved to treat the core symptoms or cognitive and behavioral problems associated with autism. Therefore, there is an urgent need to develop an effective and safe treatment.In this study, we aim to share our 2-year experience with CBD-enriched cannabis treatment in autism and review the latest studies.The study included 33 (27 males, six females) children diagnosed with autism spectrum disorder who were followed up between January 2018 and August 2020. The mean age was 7.7 ± 5.5 years. The average daily dosage of cannabidiol (CBD) was 0.7 mg/kg/day (0.3-2 mg/kg/day). The median duration of treatment was 6.5 months (3-28 months). The preparations used in this study contained full-spectrum CBD and trace elements tetrahydrocannabinol (THC) of less than 3%.The outcomes were evaluated before and after treatment based on clinical interviews. At each follow-up visit, parents were asked to evaluate the effectiveness of the CBD-enriched cannabis treatment. According to the parents' reports, no change in daily life activity was reported in 6 (19.35%) patients. The main improvements of the treatment were as follows: a decrease in behavioral problems was reported in 10 patients (32.2%), an increase in expressive language was reported in 7 patients (22.5%), improved cognition was reported in 4 patients (12,9%), an increase in social interaction was reported in 3 patients (9.6%), and a decrease in stereotypes was reported in 1 patient (3.2%). The parents reported improvement in cognition among patients who adhered to CBD-enriched cannabis treatment for over two years. The antipsychotic drug could be stopped only in one patient who showed mild ASD symptoms. No change could be made in other drug use and doses. Additionally, this study includes an extensive review of the literature regarding CBD treatment in autism spectrum disorder. According to recent studies, the average dose of CBD was 3.8±2.6 mg/kg/day. The ratio of CBD to THC in the used preparations was 20:1. The most significant improvements were seen in the behavioral problems reported in 20-70% of the patients.Using lower doses of CBD and trace THC seems to be promising in managing behavioral problems associated with autism. In addition, this treatment could be effective in managing the core symptoms and cognitive functions. No significant side effects were seen at the low doses of CBD-enriched cannabis when compared to other studies." @default.
• W4200430478 created "2021-12-31" @default.
• W4200430478 creator A5016360539 @default.
• W4200430478 creator A5054028372 @default.
• W4200430478 date "2021-12-01" @default.
• W4200430478 modified "2023-10-18" @default.
• W4200430478 title "CBD-enriched cannabis for autism spectrum disorder: an experience of a single center in Turkey and reviews of the literature" @default.
• W4200430478 cites W1496162310 @default.
• W4200430478 cites W2036600731 @default.
• W4200430478 cites W2037000265 @default.
• W4200430478 cites W2062417095 @default.
• W4200430478 cites W2149110258 @default.
• W4200430478 cites W2158282742 @default.
• W4200430478 cites W2162507318 @default.
• W4200430478 cites W2753542395 @default.
• W4200430478 cites W2899228386 @default.
• W4200430478 cites W2906483345 @default.
• W4200430478 cites W2909240409 @default.
• W4200430478 cites W2912974605 @default.
• W4200430478 cites W2927861055 @default.
• W4200430478 cites W2953662225 @default.
• W4200430478 cites W2980477754 @default.
• W4200430478 cites W2985225958 @default.
• W4200430478 cites W2987709519 @default.
• W4200430478 cites W3040352458 @default.
• W4200430478 cites W3042473032 @default.
• W4200430478 cites W3093022219 @default.
• W4200430478 cites W4247665917 @default.
• W4200430478 doi "https://doi.org/10.1186/s42238-021-00108-7" @default.
• W4200430478 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34911567" @default.
• W4200430478 hasPublicationYear "2021" @default.
• W4200430478 type Work @default.
• W4200430478 citedByCount "11" @default.
• W4200430478 countsByYear W42004304782022 @default.
• W4200430478 countsByYear W42004304782023 @default.
• W4200430478 crossrefType "journal-article" @default.
• W4200430478 hasAuthorship W4200430478A5016360539 @default.
• W4200430478 hasAuthorship W4200430478A5054028372 @default.
• W4200430478 hasBestOaLocation W42004304781 @default.
• W4200430478 hasConcept C118552586 @default.
• W4200430478 hasConcept C15744967 @default.
• W4200430478 hasConcept C169900460 @default.
• W4200430478 hasConcept C187212893 @default.
• W4200430478 hasConcept C205778803 @default.
• W4200430478 hasConcept C2776831707 @default.
• W4200430478 hasConcept C2776895053 @default.
• W4200430478 hasConcept C2777056318 @default.
• W4200430478 hasConcept C2778538070 @default.
• W4200430478 hasConcept C70410870 @default.
• W4200430478 hasConcept C71924100 @default.
• W4200430478 hasConceptScore W4200430478C118552586 @default.
• W4200430478 hasConceptScore W4200430478C15744967 @default.
• W4200430478 hasConceptScore W4200430478C169900460 @default.
• W4200430478 hasConceptScore W4200430478C187212893 @default.
• W4200430478 hasConceptScore W4200430478C205778803 @default.
• W4200430478 hasConceptScore W4200430478C2776831707 @default.
• W4200430478 hasConceptScore W4200430478C2776895053 @default.
• W4200430478 hasConceptScore W4200430478C2777056318 @default.
• W4200430478 hasConceptScore W4200430478C2778538070 @default.
• W4200430478 hasConceptScore W4200430478C70410870 @default.
• W4200430478 hasConceptScore W4200430478C71924100 @default.
• W4200430478 hasIssue "1" @default.
• W4200430478 hasLocation W42004304781 @default.
• W4200430478 hasLocation W42004304782 @default.
• W4200430478 hasLocation W42004304783 @default.
• W4200430478 hasOpenAccess W4200430478 @default.
• W4200430478 hasPrimaryLocation W42004304781 @default.
• W4200430478 hasRelatedWork W2607560691 @default.
• W4200430478 hasRelatedWork W2766418163 @default.
• W4200430478 hasRelatedWork W2766462984 @default.
• W4200430478 hasRelatedWork W3017385809 @default.
• W4200430478 hasRelatedWork W3105523296 @default.
• W4200430478 hasRelatedWork W3125217125 @default.
• W4200430478 hasRelatedWork W4206498689 @default.
• W4200430478 hasRelatedWork W4231975058 @default.
• W4200430478 hasRelatedWork W4239155938 @default.
• W4200430478 hasRelatedWork W4376155543 @default.
• W4200430478 hasVolume "3" @default.
• W4200430478 isParatext "false" @default.
• W4200430478 isRetracted "false" @default.
• W4200430478 workType "article" @default.